From Name

From Email

To Name

To Email

Message

Novel drug may lower agitation, aggression in multiple psychiatric disorders

from Medscape

Novel drug may lower agitation, aggression in multiple psychiatric disorders Medscape The novel lysine-specific demethylase 1 inhibitor vafidemstat is effective for treating agitation and aggression across a number of psychiatric disorders, new research suggests. The REIMAGINE trial included 30 patients with autism spectrum disorder, attention-deficit/hyperactivity disorder or borderline personality disorder READ MORE

more